Access Financial Services, Inc. Abb Vie Inc. Transaction History

Access Financial Services, Inc.

$184 Million
Q3 2024

A detailed history of Access Financial Services, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Access Financial Services, Inc. holds 7,238 shares of ABBV stock, worth $1.19 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

7,238

Previous 8,823 17.96%

Holding current value

$1.19 Million

Previous $1.51 Million 5.55%

% of portfolio

0.78%

Previous 0.8%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$163.84 - $199.33 $259,686 - $315,938	-1,585 Reduced 17.96%	7,238 $1.43 Million
Q2 2024 Jul 25, 2024	SELL	$154.79 - $180.76 $12,383 - $14,460	-80 Reduced 0.9%	8,823 $1.51 Million
Q1 2024 Apr 22, 2024	SELL	$159.82 - $182.1 $383,727 - $437,222	-2,401 Reduced 21.24%	8,903 $1.62 Million
Q4 2023 Jan 18, 2024	BUY	$137.6 - $154.97 $64,809 - $72,990	471 Added 4.35%	11,304 $1.75 Million
Q3 2023 Oct 25, 2023	SELL	$133.59 - $154.65 $2,938 - $3,402	-22 Reduced 0.2%	10,833 $1.61 Million
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $13,251 - $16,490	-100 Reduced 0.91%	10,855 $1.46 Million
Q1 2023 Apr 21, 2023	BUY	$144.61 - $166.54 $116,121 - $133,731	803 Added 7.91%	10,955 $1.75 Million
Q4 2022 Jan 19, 2023	SELL	$138.31 - $165.87 $87,411 - $104,829	-632 Reduced 5.86%	10,152 $0
Q3 2022 Oct 18, 2022	BUY	$134.21 - $153.93 $60,394 - $69,268	450 Added 4.35%	10,784 $1.45 Million
Q2 2022 Jul 20, 2022	SELL	$137.62 - $174.96 $327,673 - $416,579	-2,381 Reduced 18.73%	10,334 $1.58 Million
Q1 2022 Apr 19, 2022	SELL	$131.98 - $163.75 $263,960 - $327,500	-2,000 Reduced 13.59%	12,715 $2.06 Million
Q4 2021 Jan 14, 2022	BUY	$107.43 - $135.93 $21,378 - $27,050	199 Added 1.37%	14,715 $1.99 Million
Q3 2021 Oct 28, 2021	BUY	$106.4 - $120.78 $82,672 - $93,846	777 Added 5.66%	14,516 $1.57 Million
Q2 2021 Jul 15, 2021	SELL	$105.21 - $117.21 $112,259 - $125,063	-1,067 Reduced 7.21%	13,739 $1.55 Million
Q1 2021 Apr 23, 2021	SELL	$102.3 - $112.62 $96,264 - $105,975	-941 Reduced 5.98%	14,806 $1.6 Million
Q4 2020 Jan 14, 2021	BUY	$80.49 - $108.67 $8,934 - $12,062	111 Added 0.71%	15,747 $1.69 Million
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $10,566 - $12,402	123 Added 0.79%	15,636 $1.37 Million
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $4,769 - $6,381	-65 Reduced 0.42%	15,513 $1.52 Million
Q1 2020 Apr 16, 2020	BUY	$64.5 - $97.79 $14,770 - $22,393	229 Added 1.49%	15,578 $1.19 Million
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $1,154 - $1,444	16 Added 0.1%	15,349 $1.36 Million
Q3 2019 Nov 01, 2019	SELL	$62.98 - $75.72 $370,259 - $445,157	-5,879 Reduced 27.72%	15,333 $1.16 Million
Q2 2019 Jul 24, 2019	BUY	$65.7 - $83.98 $147,299 - $188,283	2,242 Added 11.82%	21,212 $1.54 Million
Q1 2019 Apr 26, 2019	BUY	$77.14 - $90.79 $128,900 - $151,710	1,671 Added 9.66%	18,970 $1.53 Million
Q4 2018 Feb 19, 2019	BUY	$77.85 - $96.01 $2,413 - $2,976	31 Added 0.18%	17,299 $1.6 Million
Q3 2018 Oct 26, 2018	BUY	$88.91 - $98.84 $260,773 - $289,897	2,933 Added 20.46%	17,268 $1.63 Million
Q2 2018 Jul 20, 2018	SELL	$89.78 - $106.23 $4,578 - $5,417	-51 Reduced 0.35%	14,335 $1.33 Million
Q1 2018 Apr 27, 2018	SELL	$92.01 - $123.21 $273,637 - $366,426	-2,974 Reduced 17.13%	14,386 $1.36 Million
Q4 2017 Jan 16, 2018	SELL	$89.56 - $98.21 $105,680 - $115,887	-1,180 Reduced 6.36%	17,360 $1.68 Million
Q3 2017 Nov 02, 2017	BUY	$69.85 - $89.22 $1.3 Million - $1.65 Million	18,540	18,540 $1.65 Million

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Access Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Access Financial Services, Inc. with notifications on news.

Account

Access Financial Services, Inc. Abb Vie Inc. Transaction History